- Home
- ARDX vs UAN Comparison
ARDX vs UAN Comparison
Compare ARDX & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARDX
- UAN
- Stock Information
- Founded
- ARDX 2007
- UAN 2007
- Country
- ARDX United States
- UAN United States
- Employees
- ARDX N/A
- UAN N/A
- Industry
- ARDX Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- ARDX Health Care
- UAN Industrials
- Exchange
- ARDX Nasdaq
- UAN Nasdaq
- Market Cap
- ARDX 882.9M
- UAN 941.8M
- IPO Year
- ARDX 2014
- UAN 2011
- Fundamental
- Price
- ARDX $4.29
- UAN $89.00
- Analyst Decision
- ARDX Strong Buy
- UAN
- Analyst Count
- ARDX 9
- UAN 0
- Target Price
- ARDX $10.17
- UAN N/A
- AVG Volume (30 Days)
- ARDX 4.3M
- UAN 15.8K
- Earning Date
- ARDX 08-04-2025
- UAN 07-30-2025
- Dividend Yield
- ARDX N/A
- UAN 7.60%
- EPS Growth
- ARDX N/A
- UAN N/A
- EPS
- ARDX N/A
- UAN 7.13
- Revenue
- ARDX $361,706,000.00
- UAN $540,525,000.00
- Revenue This Year
- ARDX $11.39
- UAN N/A
- Revenue Next Year
- ARDX $32.84
- UAN N/A
- P/E Ratio
- ARDX N/A
- UAN $12.33
- Revenue Growth
- ARDX 127.33
- UAN N/A
- 52 Week Low
- ARDX $3.21
- UAN $62.94
- 52 Week High
- ARDX $7.18
- UAN $93.73
- Technical
- Relative Strength Index (RSI)
- ARDX 51.49
- UAN 56.06
- Support Level
- ARDX $4.27
- UAN $87.99
- Resistance Level
- ARDX $4.48
- UAN $89.43
- Average True Range (ATR)
- ARDX 0.19
- UAN 2.18
- MACD
- ARDX -0.03
- UAN -0.31
- Stochastic Oscillator
- ARDX 15.84
- UAN 51.58
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.